ICU MEDICAL INC/DE (ICUI) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
ICU MEDICAL INC/DE cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.NET INCOME (LOSS) → Net cash from operating activities: $49,219,000.00Depreciation and amortization → Operating adjustments reconciliation: $99,640,000.00Stock compensation → Operating adjustments reconciliation: $25,881,000.00Other → Operating adjustments reconciliation: $13,471,000.00Noncash lease expense → Operating adjustments reconciliation: $8,136,000.00Inventories → Operating adjustments reconciliation: $4,625,000.00(Loss) gain on disposal of property and equipment → Operating adjustments reconciliation: $1,983,000.00Debt Issuance Costs amortization → Operating adjustments reconciliation: $1,574,000.00Operating adjustments reconciliation → Net cash from operating activities: $69,840,000.00Operating adjustments reconciliation → Income taxes, including excess tax benefits and deferred income taxes: $45,301,000.00Operating adjustments reconciliation → Prepaid expenses and other current assets: $16,461,000.00Operating adjustments reconciliation → Accounts receivable: $7,562,000.00Operating adjustments reconciliation → Accrued liabilities: $5,895,000.00Operating adjustments reconciliation → Accounts payable: $4,909,000.00Operating adjustments reconciliation → Other Assets: $2,936,000.00Operating adjustments reconciliation → Equity in Earnings of Unconsolidated Affiliates: $2,406,000.00Deposit received for the sale of a business → investing reconciliation: $2,000,000.00Proceeds from sale of asset → investing reconciliation: $22,000.00investing reconciliation → Purchases of property, plant and equipment: $29,813,000.00investing reconciliation → Intangible assets additions: $3,555,000.00Net cash used in financing activities → financing reconciliation: $94,357,000.00Proceeds from exercise of stock options → financing reconciliation: $490,000.00financing reconciliation → Repayments of Long-term Debt: $54,688,000.00financing reconciliation → Payment, Tax Withholding, Share-based Payment Arrangement: $38,862,000.00financing reconciliation → Payments on finance leases: $1,297,000.00Net cash used in investing activities → investing reconciliation: $31,346,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $307,963,000.00Net cash from operating activities → Cash sources and uses: $119,059,000.00Cash sources and uses → Exchange-rate effect: $3,020,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $298,299,000.00Cash sources and uses → Net cash used in investing activities: $31,346,000.00Cash sources and uses → Net cash used in financing activities: $94,357,000.00NET INCOME (LOSS): $49,219,000.00NET INCOME (LOSS)+$49.22 MDepreciation and amortization: $99,640,000.00Depreciation & amortization+$99.64 MNoncash lease expense: $8,136,000.00Operating lease amortization+$8.14 MStock compensation: $25,881,000.00Stock-based compensation+$25.88 M(Loss) gain on disposal of property and equipment: $1,983,000.00PP&E disposal gain & loss+$1.98 MDebt Issuance Costs amortization: $1,574,000.00Debt issuance cost amortization+$1.57 MEquity in Earnings of Unconsolidated Affiliates: -$2,406,000.00Equity-method results−$2.41 MOther: $13,471,000.00Other non-cash items+$13.47 MAccounts receivable: -$7,562,000.00Accounts receivable−$7.56 MInventories: $4,625,000.00Inventories+$4.63 MPrepaid expenses and other current assets: -$16,461,000.00Prepaid & other assets−$16.46 MOther Assets: -$2,936,000.00Other operating assets−$2.94 MAccounts payable: -$4,909,000.00Accounts payable−$4.91 MAccrued liabilities: -$5,895,000.00Accrued liabilities−$5.90 MIncome taxes, including excess tax benefits and deferred income taxes: -$45,301,000.00Income taxes & deferred taxes−$45.30 MNet cash from operating activities: $119,059,000.00Operating cash+$119.06 MOperating adjustments reconciliation: $155,310,000.00Repayments of Long-term Debt: -$54,688,000.00Long-term debt repaid−$54.69 MProceeds from exercise of stock options: $490,000.00Stock option exercises+$490.00 KPayments on finance leases: -$1,297,000.00Finance lease payments−$1.30 MPayment, Tax Withholding, Share-based Payment Arrangement: -$38,862,000.00Stock-award tax withholding−$38.86 MNet cash used in financing activities: -$94,357,000.00. Cash required to fund net payments.Financing cash−$94.36 Mfinancing reconciliation: $94,847,000.00Purchases of property, plant and equipment: -$29,813,000.00PP&E purchases−$29.81 MProceeds from Sales of Business, Affiliate and Productive Assets: $0.00Deposit received for the sale of a business: $2,000,000.00Business sale deposit received+$2.00 MProceeds from sale of asset: $22,000.00PP&E sales+$22.00 KIntangible assets additions: -$3,555,000.00Intangible asset purchases−$3.56 MNet cash used in investing activities: -$31,346,000.00. Cash required to fund net payments.Investing cash−$31.35 Minvesting reconciliation: $33,368,000.00Cash sources and uses: $427,022,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $307,963,000.00Beginning cash$307.96 MEnding cash: Cash, cash equivalents, and restricted cash: $298,299,000.00Ending cash$298.30 MExchange-rate effect: -$3,020,000.00FX effect−$3.02 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$89.25 MOperating cash − cash spent on PP&ECash flow / Net income2.42×Operating cash flow ÷ net incomeNet cash change−$9.66 MEnding cash − beginning cash
Chart details

ICU MEDICAL INC/DE cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
307,963,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
119,059,000 US dollars. Net cash provided.
NET INCOME (LOSS)
49,219,000 US dollars
Depreciation and amortization
99,640,000 US dollars
Noncash lease expense
8,136,000 US dollars
Stock compensation
25,881,000 US dollars
(Loss) gain on disposal of property and equipment
1,983,000 US dollars
Debt Issuance Costs amortization
1,574,000 US dollars
Equity in Earnings of Unconsolidated Affiliates
negative 2,406,000 US dollars
Other
13,471,000 US dollars
Accounts receivable
negative 7,562,000 US dollars
Inventories
4,625,000 US dollars
Prepaid expenses and other current assets
negative 16,461,000 US dollars
Other Assets
negative 2,936,000 US dollars
Accounts payable
negative 4,909,000 US dollars
Accrued liabilities
negative 5,895,000 US dollars
Income taxes, including excess tax benefits and deferred income taxes
negative 45,301,000 US dollars
Investing activities
negative 31,346,000 US dollars. Net cash used.
Purchases of property, plant and equipment
negative 29,813,000 US dollars
Proceeds from Sales of Business, Affiliate and Productive Assets
0 US dollars
Deposit received for the sale of a business
2,000,000 US dollars
Proceeds from sale of asset
22,000 US dollars
Intangible assets additions
negative 3,555,000 US dollars
Financing activities
negative 94,357,000 US dollars. Net cash used.
Repayments of Long-term Debt
negative 54,688,000 US dollars
Proceeds from exercise of stock options
490,000 US dollars
Payments on finance leases
negative 1,297,000 US dollars
Payment, Tax Withholding, Share-based Payment Arrangement
negative 38,862,000 US dollars
Operating adjustment reconciliation
155,310,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
94,847,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
33,368,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 3,020,000 US dollars
Ending cash on Jun 30, 2026
298,299,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
427,022,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 9,664,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.42×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
119,059,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
29,813,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
89,246,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $69.84M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 119,059,000 US dollars minus 29,813,000 US dollars equals 89,246,000 US dollars.
ICU MEDICAL INC/DE (ICUI) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!